NEKTAR THERAPEUTICS (NKTR)
Latest NKTR Insider Trades
About NEKTAR THERAPEUTICS (NKTR)
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
- SAN FRANCISCO, CA
- 63
- 1994
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 8 | 31,823 | $1.99M |
| Grant or award | 2 | 73,700 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
NKTR Insider Transactions (Form 4)
5640 Form 4 filings on record, the earliest from Nov 20, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jonathan Zalevsky - Officer | Open-market sale | Common Stock | 186 |
Recent NKTR Form 8-K Filings
5Recent NKTR Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Zalevsky Jonathan | Officer | 186 | $13K | View on EDGAR | |
| ROBIN HOWARD W | Officer, Director |
NKTR Insider Trading - FAQ
What is the latest insider trade for NKTR?
NEKTAR THERAPEUTICS (NKTR) had 7 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for NKTR runs to 40 Form 4 filings, the earliest from 2024-11-20. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying NKTR stock?
No insider purchases of NKTR were filed in the last 90 days.
How many insiders are selling NKTR stock?
8 insider sales of NKTR were filed in the last 90 days, totaling $1.99M.
Where can I see NKTR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks NKTR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow NKTR insider buys?
Create a free InsiderAlpha account and press Watch on this page to add NKTR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Jonathan Zalevsky view on EDGAR
- - Howard W. Robin view on EDGAR
- - Jonathan Zalevsky view on EDGAR
- - Howard W. Robin view on EDGAR
- - Jonathan Zalevsky view on EDGAR
- - Howard W. Robin view on EDGAR
- - Jonathan Zalevsky view on EDGAR
- - Jonathan Zalevsky view on EDGAR
- - Howard W. Robin view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where NKTR's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track NKTR insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
